US Stocks
/
Arcutis Biotherapeutics, Inc. Share Price

Arcutis Biotherapeutics, Inc. Share Price

NASDAQ: ARQT | Mid Cap
$24.48
+$0.30 (1.26%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Arcutis Biotherapeutics, Inc. Stock Performance

Open
$23.77
Prev. Close
$24.18
Circuit Range
N/A
Day Range
$23.38 - $24.55
Year Range
$19.30 - $31.75
Volume
1,26,002
Average Traded
$24.03

Arcutis Biotherapeutics, Inc. Share Price Today

As of 9 October 2026, Arcutis Biotherapeutics, Inc.'s share price is $24.48. The stock opened at $23.77, compared to its previous close of $24.18. During today's trading session, Arcutis Biotherapeutics, Inc.'s share price traded between $23.38 and $24.55, with an average price of $23.96. Over the past 52 weeks, the stock has recorded a high of $31.75 and a low of $19.30. In terms of performance, Arcutis Biotherapeutics, Inc.'s share price has risen by 5.47% over the last six months and is down 3.32% on a year-on-year basis.

Arcutis Biotherapeutics, Inc. Share Price Chart

$23.38$24.55
L
Show Current Price
H

Arcutis Biotherapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$3.11B
PE Ratio (TTM)
106.52
Dividend Yield
0.00%
EPS (TTM)
$0.23
Revenue (TTM)
$376.07B
Return On Equity (TTM)
12.93%
Profit Margin
-4.29%
Debt to Equity
0.49
Quarterly Earnings Growth YoY
102.56%

Arcutis Biotherapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$99.22$129.50$105.40$129.86
Net Profit$7.41$17.40-$11.30$15.01
Net Profit Margin7.47%13.44%-10.72%11.56%
Income ChangeN/A134.82%-164.94%232.83%

Arcutis Biotherapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$3.69$59.61$196.54$376.07
Net Profit-$311.46-$262.14-$140.04-$16.14
Net Profit Margin-8440.65%-439.76%-71.25%-4.29%
Income ChangeN/A15.84%46.58%88.47%

About Arcutis Biotherapeutics, Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

Arcutis Biotherapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$26.07
$24.46
-7.54%
Sep 2026
$24.00
$26.46
+6.41%
Aug 2026
$26.39
$24.86
-7.41%
Jul 2026
$26.35
$26.86
+2.30%
Jun 2026
$21.30
$26.25
+22.21%
May 2026
$23.12
$21.48
-7.45%
Apr 2026
$23.80
$23.21
-1.55%
Mar 2026
$25.90
$23.57
-12.59%
Feb 2026
$25.02
$26.97
+6.18%
Jan 2026
$28.89
$25.40
-12.53%
Dec 2025
$30.14
$29.04
-5.27%
Nov 2025
$25.20
$30.66
+21.07%

ARQT Share Price FAQs

What is Arcutis Biotherapeutics, Inc. share price today?

chevron-up
Arcutis Biotherapeutics, Inc. share price today is $24.48 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Arcutis Biotherapeutics, Inc. stock?

chevron-up
The 52 week high of Arcutis Biotherapeutics, Inc. stock is $31.75, while the 52 week low is $19.30 as of 9 Oct '26.

What is ARQT's market capitalisation today?

chevron-up
ARQT market capitalisation is $3.11B as of October 9, 2026, at 9:54 am IST.

What is ARQT's net income for the last quarter?

chevron-up
ARQT's net income for the last quarter is 15.01B USD.

What is the 5 year returns of ARQT?

chevron-up
The 5 year returns of ARQT is 15.47% as on 9 Oct '26.

What is the high & low stock price of ARQT today?

chevron-up
ARQT stock price hit a high of $24.55 and low of $23.38 as of 9 Oct '26.

Can I buy ARQT shares in India?

chevron-up
Yes. You can buy ARQT in India by opening an international trading account.